Extrathymic development and function of human T-lymphocytes from bone marrow cells in vitro.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 8118889)

Published in Cell Immunol on March 01, 1994

Authors

M Adibzadeh1, H J Bühring, T Daikeler, P Siegels-Hübenthal, M Owsianowsky, A Schenk, A Rehbein, K Schaudt, E Schlotz, H Pohla

Author Affiliations

1: Medical and Natural Sciences Research Center, University of Tübingen, Federal Republic of Germany.

Articles by these authors

CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity. J Virol (1987) 4.58

Procyclin gene expression and loss of the variant surface glycoprotein during differentiation of Trypanosoma brucei. J Cell Biol (1989) 2.60

The sialomucin CD164 (MGC-24v) is an adhesive glycoprotein expressed by human hematopoietic progenitors and bone marrow stromal cells that serves as a potent negative regulator of hematopoiesis. Blood (1998) 2.37

Flk-1 expression defines a population of early embryonic hematopoietic precursors. Development (1997) 2.32

Cloned long-term cytolytic T-lymphocyte line with specificity for an immediate-early membrane antigen of murine cytomegalovirus. J Virol (1986) 1.86

Human signal-regulatory protein is expressed on normal, but not on subsets of leukemic myeloid cells and mediates cellular adhesion involving its counterreceptor CD47. Blood (1999) 1.77

The Internet as recruitment tool for HIV studies: viable strategy for reaching at-risk Hispanic MSM in Miami? AIDS Care (2004) 1.67

The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes. Cancer Res (2001) 1.50

Signal-regulatory protein alpha (SIRPalpha) but not SIRPbeta is involved in T-cell activation, binds to CD47 with high affinity, and is expressed on immature CD34(+)CD38(-) hematopoietic cells. Blood (2001) 1.44

Giant cell arteritis--a changing entity. Swiss Med Wkly (2011) 1.42

Simultaneous expression of CD4 and CD8 antigens by a substantial proportion of resting porcine T lymphocytes. Eur J Immunol (1987) 1.41

Cutting edge: signal-regulatory protein beta 1 is a DAP12-associated activating receptor expressed in myeloid cells. J Immunol (2000) 1.41

Human FLT3/FLK2 receptor tyrosine kinase is expressed at the surface of normal and malignant hematopoietic cells. Leukemia (1996) 1.38

Determination of cytokines in synovial fluids: correlation with diagnosis and histomorphological characteristics of synovial tissue. Ann Rheum Dis (1992) 1.36

Failure in generating hemopoietic stem cells is the primary cause of death from cytomegalovirus disease in the immunocompromised host. J Exp Med (1988) 1.34

Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinase. Blood (1997) 1.30

Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay. Nat Med (2001) 1.30

Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts. Int Immunol (1992) 1.28

Sensitivity enhancement in fluorescence correlation spectroscopy of multiple species using time-gated detection. Biophys J (2000) 1.27

Association of signal-regulatory proteins beta with KARAP/DAP-12. Eur J Immunol (2000) 1.13

Immunosenescence: ageing of the immune system. Immunol Today (1995) 1.13

Specific antibodies elicited by antigen covalently linked to a synthetic adjuvant. Immunobiology (1985) 1.12

Lysis of prostate carcinoma cells by trifunctional bispecific antibodies (alpha EpCAM x alpha CD3). J Histochem Cytochem (2001) 1.11

An attempt to produce "pre-T" cell hybridomas and to identify their antigens. Eur J Immunol (1986) 1.10

Physical properties and function of phallolysin. Biochemistry (1983) 1.09

Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis. Ann Rheum Dis (2007) 1.09

Human versus porcine mesenchymal stromal cells: phenotype, differentiation potential, immunomodulation and cardiac improvement after transplantation. J Cell Mol Med (2012) 1.08

Monoclonal antibodies reactive with swine lymphocytes. II. Detection of an antigen on resting T cells down-regulated after activation. J Immunol (1987) 1.08

Differential secretion of tumor necrosis factor-alpha and granulocyte/macrophage colony-stimulating factors but not interferon-gamma from CD4+ compared to CD8+ human T cell clones. Eur J Immunol (1989) 1.08

Aged murine killer T-cell clones acquire specific cytotoxicity for P815 mastocytoma cells. Nature (1984) 1.08

Expression and signal transduction of the FLT3 tyrosine kinase receptor. Acta Haematol (1996) 1.04

The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis. BMC Cancer (2006) 1.04

The Tie receptor tyrosine kinase is expressed by human hematopoietic progenitor cells and by a subset of megakaryocytic cells. Blood (1996) 1.03

Properdin, a positive regulator of complement activation, is expressed in human T cell lines and peripheral blood T cells. J Immunol (1993) 1.02

Thermoregulated expression of virulence factors in plant-associated bacteria. Arch Microbiol (2001) 1.02

Human T-cell clones in long-term culture as a model of immunosenescence. Immunol Rev (1997) 1.01

Rapid improvement of nailfold capillaroscopy after intense immunosuppression for systemic sclerosis and mixed connective tissue disease. Ann Rheum Dis (2008) 1.00

Isolation of highly purified autologous and allogeneic peripheral CD34+ cells using the CliniMACS device. J Hematother (1999) 1.00

Familial inflammatory Sneddon's syndrome-case report and review of the literature. Clin Rheumatol (2004) 0.99

Membrane protein reconstitution and crystallization by controlled dilution. FEBS Lett (2003) 0.99

Expression of MUC-1 epitopes on normal bone marrow: implications for the detection of micrometastatic tumor cells. J Clin Oncol (1999) 0.98

Analysis of Tie receptor tyrosine kinase in haemopoietic progenitor and leukaemia cells. Br J Haematol (1997) 0.98

HSP expression in human leukocytes is modulated by endurance exercise. Med Sci Sports Exerc (2000) 0.98

E-cadherin is functionally involved in the maturation of the erythroid lineage. J Cell Biol (1995) 0.97

The product of the proto-oncogene c-kit (P145c-kit) is a human bone marrow surface antigen of hemopoietic precursor cells which is expressed on a subset of acute non-lymphoblastic leukemic cells. Leukemia (1991) 0.97

Preoperative volume prediction in adult living donor liver transplantation: how much can we rely on it? Am J Transplant (2007) 0.97

Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-x(L). Hum Pathol (2001) 0.96

IL-4-responsive human helper T cell clones are resistant to growth inhibition by tumor necrosis factor-alpha. J Immunol (1989) 0.96

Transcriptional and translational regulation of heat shock proteins in leukocytes of endurance runners. J Appl Physiol (1985) (2000) 0.96

ICOS-Dependent and -independent functions of memory CD4 T cells in allograft rejection. Am J Transplant (2008) 0.94

Determination of the electrophoretic mobility of chromosomes by free flow electrophoresis. I. Morphology and stability. Electrophoresis (1989) 0.94

CD164, a novel sialomucin on CD34(+) and erythroid subsets, is located on human chromosome 6q21. Blood (1998) 0.93

Immunosenescence, suppression and tumour progression. Cancer Immunol Immunother (2005) 0.93

Serum procalcitonin for discrimination between septic and non-septic arthritis. Clin Exp Rheumatol (2008) 0.93

CD164 monoclonal antibodies that block hemopoietic progenitor cell adhesion and proliferation interact with the first mucin domain of the CD164 receptor. J Immunol (2000) 0.92

A case of bone marrow mastocytosis associated with multiple myeloma. Ann Hematol (1998) 0.92

Soluble T cell receptor-like properties of an HLA-B35-specific monoclonal antibody (TU165). Eur J Immunol (1993) 0.91

Quantification of VP22-GFP spread by direct fluorescence in 15 commonly used cell lines. J Gene Med (2000) 0.91

Long-term culture, cloning, and surface markers of mixed leukocyte culture-derived human T lymphocytes with natural killer-like cytotoxicity. J Immunol (1982) 0.91

Preclinical studies with Fc(gamma)R bispecific antibodies and granulocyte colony-stimulating factor-primed neutrophils as effector cells against HER-2/neu overexpressing breast cancer. Cancer Res (1997) 0.90

AML: immunophenotypic heterogeneity and prognostic significance of c-kit expression. Leukemia (1994) 0.90

Ex situ quantification of the cooling effect of liver vessels on radiofrequency ablation. Langenbecks Arch Surg (2009) 0.89

Sclerosing skin disorders in association with multiple sclerosis. Coincidence, underlying autoimmune pathology or interferon induced? Ann Rheum Dis (2008) 0.89

Epitope mapping and functional studies with three monoclonal antibodies to the c-kit receptor tyrosine kinase, YB5.B8, 17F11, and SR-1. J Cell Physiol (1994) 0.89

Lower limb pitting edema in systemic lupus erythematosus. Rheumatol Int (1999) 0.89

Phase II study of continuous 120 h infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent colorectal cancer. Anticancer Drugs (1998) 0.88

Functionally defined CD164 epitopes are expressed on CD34(+) cells throughout ontogeny but display distinct distribution patterns in adult hematopoietic and nonhematopoietic tissues. Blood (2000) 0.88

Comparison of the immunosuppressive activities of the antimycotic agents itraconazole, fluconazole, ketoconazole and miconazole on human T-cells. Int J Immunopharmacol (1991) 0.88

Autologous stem cell transplantation of treatment-resistant systemic vasculitis--a single center experience and review of the literature. Clin Nephrol (2005) 0.87

Expression of MHC class II epitopes on human T lymphocyte clones. Cell Immunol (1990) 0.87

Cutting edge: characterization of allorestricted and peptide-selective alloreactive T cells using HLA-tetramer selection. J Immunol (2001) 0.87

Upregulation of frizzled 9 in astrocytomas. Neuropathol Appl Neurobiol (2006) 0.87

Removal of fibroblastoid cells from primary monolayer cultures of rat neonatal endocrine pancreas by sodium ethylmercurithiosalicylate. Biochem Biophys Res Commun (1974) 0.87

Hymenoptera-venom-induced upregulation of the basophil activation marker ecto-nucleotide pyrophosphatase/phosphodiesterase 3 in sensitized individuals. Int Arch Allergy Immunol (2001) 0.87

Characterization of 125I-glucagon binding in a solubilized preparation of cat myocardial adenylate cyclase. Further evidence for a dissociable receptor site. J Biol Chem (1974) 0.86

AC133 antigen expression is not restricted to acute myeloid leukemia blasts but is also found on acute lymphoid leukemia blasts and on a subset of CD34+ B-cell precursors. Blood (1999) 0.86

Transmission of psoriatic arthritis by allogeneic bone marrow transplantation for chronic myelogenous leukaemia from an HLA-identical donor. Rheumatology (Oxford) (1999) 0.86

Long-term culture of monoclonal human T lymphocytes: models for immunosenescence? Mech Ageing Dev (1995) 0.86

Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study. Gene Ther (2010) 0.86

Unicellular-unilineage erythropoietic cultures: molecular analysis of regulatory gene expression at sibling cell level. Blood (1999) 0.85

Analysis of c-kit receptor dimerization by fluorescence resonance energy transfer. Blood (1998) 0.85

Retention of specific proliferative capacity of cloned human T cells alloactivated against HLA-D alleles. Immunogenetics (1980) 0.84

High incidence of severe ischaemic complications in patients with giant cell arteritis irrespective of platelet count and size, and platelet inhibition. Rheumatology (Oxford) (2009) 0.84

Decreased proliferative capacity and increased susceptibility to activation-induced cell death in late-passage human CD4+ TCR2+ cultured T cell clones. Exp Gerontol (1998) 0.84

Alloproliferative human T cell clones primed and cultured in vitro lose proliferative and gain suppressive activity with age. Hum Immunol (1984) 0.84

Variable expression of activation-linked surface antigens on human mast cells in health and disease. Immunol Rev (2001) 0.84

[Evaluation of a new software tool for the automatic volume calculation of hepatic tumors. First results]. Rofo (2004) 0.84

Magnetic resonance imaging guided corticosteroid injection of the sacroiliac joints in patients with therapy resistant spondyloarthropathy: a pilot study. J Rheumatol (2000) 0.83

Human T lymphocytes grown in T-cell growth factor: functional attributes in MLC, CML, PLT and allogeneic suppression. Immunology (1981) 0.83

Mitomycin C continuous infusion as salvage chemotherapy in pretreated patients with advanced gastric cancer. Anticancer Drugs (1999) 0.83

Pseudotype formation of Moloney murine leukemia virus with Sendai virus glycoprotein F. J Virol (1998) 0.83

Stable expression of clonal specificity in murine cytomegalovirus-specific large granular lymphoblast lines propagated long-term in recombinant interleukin 2. Immunobiology (1987) 0.83

Molecular biology of the HLA-B27 locus. Br J Rheumatol (1988) 0.83

HLA-DP in rheumatoid arthritis. Tissue Antigens (1988) 0.83

Division of human helper T cells into two sets on the basis of the induction of anti-tumor cytotoxicity by phorbol ester and calcium ionophore. Eur J Immunol (1988) 0.82